USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
15.27
-0.19 (-1.23%)
Oct 14, 2026, 4:00 PM EDT - Market closed
USANA Health Sciences Financials Overview
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 913.36 | 925.26 | 854.5 | 921.01 | 998.6 | 1,186 |
Revenue Growth | 1.57% | 8.28% | -7.22% | -7.77% | -15.83% | 4.57% |
Gross Profit Gross Profit Growth | 707.36 | 724.41 | 693.29 | 744.32 | 804.71 | 968.57 |
Operating Income Operating Income Growth | 41.49 | 50.86 | 74.57 | 93.07 | 107.61 | 170.19 |
Net Income Net Income Growth | -22.16 | 10.76 | 42.03 | 63.79 | 69.35 | 116.51 |
Earnings Per Share EPS Growth | -1.21 | 0.58 | 2.19 | 3.30 | 3.59 | 5.73 |
EPS Growth | - | -73.52% | -33.64% | -8.08% | -37.35% | -2.22% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Core nutritional Core nutritional Growth | 761.14 | 775.45 | 845.79 | 915.21 | 995.04 | 1,186 |
Hiya Hiya Growth | 121.36 | 131.97 | 1.97 | - | - | - |
Other Other Growth | - | 17.83 | 6.74 | 5.8 | 3.56 | - |
Total Total Growth | 913.36 | 925.26 | 854.5 | 921.01 | 998.6 | 1,186 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 168.56 | 158.38 | 181.77 | 330.42 | 288.42 | 239.83 |
Total Debt Total Debt Growth | - | 31.96 | 39.2 | 13.21 | 14.57 | 17.3 |
Net Cash (Debt) Net Cash Growth | 168.56 | 126.42 | 142.56 | 317.22 | 273.85 | 222.54 |
Net Cash Growth | 11.38% | -11.32% | -55.06% | 15.84% | 23.06% | -23.38% |
Net Cash Per Share Net Cash Per Share Growth | 9.18 | 6.81 | 7.44 | 16.40 | 14.18 | 10.94 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 27.73 | 22.35 | 60.99 | 70.64 | 103.9 | 121.23 |
Capital Expenditures CapEx Growth | -11.79 | -13.82 | -10.07 | -14.49 | -10.4 | -12.76 |
Free Cash Flow Free Cash Flow Growth | 15.93 | 8.53 | 50.92 | 56.15 | 93.5 | 108.46 |
Free Cash Flow Growth | -68.75% | -83.26% | -9.31% | -39.95% | -13.79% | -25.36% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 77.45% | 78.29% | 81.13% | 80.81% | 80.58% | 81.64% |
Operating Margin | 4.54% | 5.50% | 8.73% | 10.11% | 10.78% | 14.34% |
Pretax Margin | 0.28% | 4.49% | 8.94% | 11.12% | 10.88% | 14.38% |
Profit Margin | -2.43% | 1.16% | 4.92% | 6.93% | 6.94% | 9.82% |
FCF Margin | 1.75% | 0.92% | 5.96% | 6.10% | 9.36% | 9.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 15, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 33.03 | 16.18 | 16.07 | 14.73 | 16.91 |
Forward PE | 14.97 | 11.17 | 14.31 | 19.85 | 17.05 | 19.17 |
P/FCF Ratio | 17.71 | 41.68 | 13.36 | 18.26 | 10.93 | 18.16 |
PS Ratio | 0.31 | 0.38 | 0.80 | 1.11 | 1.02 | 1.66 |